Designer peptide antagonist of the leptin receptor with peripheral antineoplastic activity
Authors:
- Serena BeccariSBSerena Beccari
- Ilona KovalszkyIKIlona Kovalszky
- John D. WadeJWJohn D. Wade
- Laszlo OtvosLOLaszlo Otvos
- Eva SurmaczESEva Surmacz
Abstract
No abstract availableKeywords
Funding Information
- Sbarro Health Research Organization
- Pennsylvania Department of Health
This publication has 40 references indexed in Scilit:
- Glioblastoma-derived Leptin Induces Tube Formation and Growth of Endothelial Cells: Comparison with VEGF EffectsBMC Cancer, 2011
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010
- Obesity and breast cancer: status of leptin and adiponectin in pathological processesCancer and Metastasis Reviews, 2010
- Leptin as a potential therapeutic target for breast cancer prevention and treatmentExpert Opinion on Therapeutic Targets, 2010
- Novel mechanism for obesity-induced colon cancer progressionCarcinogenesis, 2009
- Development of a pharmacologically improved peptide agonist of the leptin receptorBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- Leptin Interferes with the Effects of the Antiestrogen ICI 182,780 in MCF-7 Breast Cancer CellsClinical Cancer Research, 2004
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- Multicellular spheroids: a three‐dimensionalin vitroculture system to study tumour biologyInternational Journal of Experimental Pathology, 1998
- Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acidsInternational Journal of Peptide and Protein Research, 1990